Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) and JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) belong to the same industry segment: US Mid Cap. IQSM's top 3 sector exposures are Industrials, Information Technology and Health Care. In contrast, BBMC's top sector exposures are Industrials, Financials and Information Technology. IQSM is more expensive with a Total Expense Ratio (TER) of 0.16%, versus 0.07% for BBMC. IQSM is up 1.9% year-to-date (YTD) with +$61M in YTD flows. BBMC performs worse with 1.43% YTD performance, and +$31M in YTD flows. Run a side-by-side ETF comparison of IQSM and BBMC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IQSM BBMC | -4.41%-4.67% | +0.05%+0.14% | +1.90%+1.43% | +17.13%+21.62% | +39.89%+55.71% | n/a+31.33% |
| Flows | IQSM BBMC | +$45M-$6M | +$60M-$146M | +$61M+$31M | +$44M-$240M | +$219M-$294M | --$282M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IQSM BBMC | +14.56%+16.16% | +20.37%+21.58% | +17.45%+18.72% | n/a+20.67% |
| Max drawdown | IQSM BBMC | -5.34%-7.05% | -15.27%-15.74% | -23.67%-24.17% | n/a-30.03% |
| Max drawdown duration | IQSM BBMC | 13d14d | 46d46d | 379d275d | n/a1045d |
IQSM | BBMC | |
Last sale 3/12/2026 at 7:44 PM | $34.57 | $108.90 |
| Previous close 03/12/2026 | $35.30 | $108.09 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IQSM | BBMC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IQSM | BBMC | |
|---|---|---|
| Last price | $34.57 | $108.90 |
| 1D performance | -2.05% | +0.75% |
| AuM | $270.02 M | $1.86 B |
| E/R | 0.16% | 0.07% |
IQSM | BBMC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | New York Life Investments | J.P. Morgan Asset Management |
| Benchmark | NYLI Candriam U.S. Mid Cap Equity Index | Morningstar US Mid Cap Target Market Exposure Extended Index |
| N° of holdings | 219 | 512 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 25, 2022 | April 14, 2020 |
| ESG | Yes | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
